• Publications
  • Influence
Pain assessment: global use of the Brief Pain Inventory.
TLDR
The development of the Brief Pain Inventory and the various applications to which the BPI is suited are described, being adopted in many countries for clinical pain assessment, epidemiological studies, and in studies of the effectiveness of pain treatment.
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.
TLDR
Systematically collecting and reporting the recommended information needed to evaluate the clinical importance of treatment outcomes of Chronic pain clinical trials will allow additional validation of proposed benchmarks and provide more meaningful comparisons of chronic pain treatments.
The rapid assessment of fatigue severity in cancer patients
TLDR
The Brief Fatigue Inventory was developed for the rapid assessment of fatigue severity for use in both clinical screening and clinical trials.
Pain and its treatment in outpatients with metastatic cancer.
TLDR
The adequacy of prescribed analgesic drugs using guidelines developed by the World Health Organization was assessed, the factors that influenced whether analgesia was adequate were studied, and the effects of inadequate analgesia on the patients' perception of pain relief and functional status were determined.
Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.
TLDR
The core items of the MDASI accounted for the majority of symptom distress reported by cancer patients in active treatment and those who were followed after treatment.
Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases
TLDR
The development of a self‐report instrument designed to assess pain in cancer and other diseases and the evaluated Wisconsin Brief Pain Questionnaire suggest that the BPQ is sufficiently reliable and valid for research purposes.
Validity of the Brief Pain Inventory for Use in Documenting the Outcomes of Patients With Noncancer Pain
TLDR
Results support the validity of the BPI as a measure of pain in patients without cancer and, in particular, as aMeasure of pain for arthritis and LBP patients.
When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function
TLDR
The hypothesis was that mild, moderate, and severe pain would differentially impair cancer patients' function, and optimal cutpoints were found that form 3 distinct levels of pain severity that can be defined on a 0–10‐point numerical scale.
Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.
TLDR
It is suggested that once-weekly epoetin alfa therapy increases hemoglobin levels, decreases transfusion requirements, and improves quality of life in patients with cancer and anemia who undergo concomitant chemotherapy.
...
1
2
3
4
5
...